The need to accurately document novel coronavirus cases, manage vaccine administration, and analyze and share patient data, is critical to patients, their communities, and the healthcare professionals who serve them.
To support our healthcare partners and the entire HIT community, IMO is committed to delivering the most up-to-date terminology and insights solutions to help in the fight against this global pandemic.
*Requires IMO Core
**Available free of charge to IMO customers
***Available free of charge to non-IMO customers
Still wondering how IMO’s COVID-19 solutions can help your organization?
Our team is ready to answer any questions you may have. Ask away.
In part two of our four-part blog series about COVID-19 variants, we explained the importance of data harmonization, which must occur before sequencing, clinical, and epidemiologic data can be combined. In part three, we look at how to maintain the link between patients and their sequence.
Back in May, IMO’s Chief Clinical Officer, Steven Rube, MD, FAMIA, sat down with HIMSS to talk about how the COVID-19 pandemic has highlighted key areas in clinical documentation where the process of recording patient information is not intuitive – and why having greater specificity in clinical notes is critical to making the most of the patient record.
As the COVID-19 pandemic continues to impact daily life, addressing interoperability in healthcare is critically important. So, we pored over the most recent legislation on the topic – the 21st Century Cures Act – and learned about the new responsibilities payers have in healthcare interoperability. Read a snippet of our summary below.
